A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction - A Case Report
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Phenylephrine is a sympathomimetic, which means it acts analogous to adrenaline. Phenylephrine can be taken orally to treat nasal congestion symptoms. It is also frequently mixed with other medicines in products meant to relieve cough and cold symptoms. Given the widespread usage of phenylephrine, related drug eruptions appear to be uncommon.
CASE PRESENTATION: Here we discuss a case of a 19-year-old female patient who reported to our hospital with blebs on the skin throughout her legs and torso. The drug eruption or adverse drug response was linked with itching, had a slow beginning, and progressed. Her medical history indicated that she had been taking phenylephrine 10 mg orally twice a day. On the sixth day, she experienced an adverse medication response caused by the medicine phenylephrine. Phenylephrine was stopped immediately and the other medications, such as levocetirizine, montelukast, and nasal spray, were continued. The patient was told not to use phenylephrine, either alone or in combination with FDCs. There are no other complaints. As a result, the patient was diagnosed with phenylephrine- induced eruption.
CONCLUSION: We present this case to highlight the importance of inspiring a pharmacovigilance mindset among all clinicians providing care as a routine alert drug, phenylephrine-induced drug eruption.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Current drug safety - 19(2024), 2 vom: 27., Seite 291-294 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yella, Sree Sudha Tanguturi [VerfasserIn] |
---|
Links: |
---|
Themen: |
1WS297W6MV |
---|
Anmerkungen: |
Date Completed 10.01.2024 Date Revised 10.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1574886318666230601162144 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35766678X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM35766678X | ||
003 | DE-627 | ||
005 | 20240114233331.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1574886318666230601162144 |2 doi | |
028 | 5 | 2 | |a pubmed24n1255.xml |
035 | |a (DE-627)NLM35766678X | ||
035 | |a (NLM)37264618 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yella, Sree Sudha Tanguturi |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction - A Case Report |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.01.2024 | ||
500 | |a Date Revised 10.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a BACKGROUND: Phenylephrine is a sympathomimetic, which means it acts analogous to adrenaline. Phenylephrine can be taken orally to treat nasal congestion symptoms. It is also frequently mixed with other medicines in products meant to relieve cough and cold symptoms. Given the widespread usage of phenylephrine, related drug eruptions appear to be uncommon | ||
520 | |a CASE PRESENTATION: Here we discuss a case of a 19-year-old female patient who reported to our hospital with blebs on the skin throughout her legs and torso. The drug eruption or adverse drug response was linked with itching, had a slow beginning, and progressed. Her medical history indicated that she had been taking phenylephrine 10 mg orally twice a day. On the sixth day, she experienced an adverse medication response caused by the medicine phenylephrine. Phenylephrine was stopped immediately and the other medications, such as levocetirizine, montelukast, and nasal spray, were continued. The patient was told not to use phenylephrine, either alone or in combination with FDCs. There are no other complaints. As a result, the patient was diagnosed with phenylephrine- induced eruption | ||
520 | |a CONCLUSION: We present this case to highlight the importance of inspiring a pharmacovigilance mindset among all clinicians providing care as a routine alert drug, phenylephrine-induced drug eruption | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Drug eruption | |
650 | 4 | |a adverse drug reaction | |
650 | 4 | |a levocetirizine. | |
650 | 4 | |a pharmacovigilance | |
650 | 4 | |a phenylephrine | |
650 | 4 | |a sympathomimetic | |
650 | 7 | |a Phenylephrine |2 NLM | |
650 | 7 | |a 1WS297W6MV |2 NLM | |
650 | 7 | |a Nonprescription Drugs |2 NLM | |
700 | 1 | |a Krishna Sasanka, Kota Sesha Brahma Sri |e verfasserin |4 aut | |
700 | 1 | |a Singh, Harminder |e verfasserin |4 aut | |
700 | 1 | |a Meena, Bhumika |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 19(2024), 2 vom: 27., Seite 291-294 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2024 |g number:2 |g day:27 |g pages:291-294 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886318666230601162144 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2024 |e 2 |b 27 |h 291-294 |